By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
News

Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime

Last updated: 16/12/2025 5:36 PM
Published: 16/12/2025
Share
SHARE

HUNTSVILLE, Ala., Dec. 15, 2025 /PRNewswire/ — Titomic Limited (ASX: TTT), a global leader in cold spray additive manufacturing utilizing their Titomic Kinetic Fusion™ technology, is pleased to announce it has secured an Early Manufacturing Development (EMD) contract with a leading defense prime contractor to support a new effort for production of next-generation defense articles. The collaboration will establish and validate an innovative manufacturing approach intended to accelerate production, improve supply-chain resilience, and deliver critical components to the warfighter faster. The initial EMD contract is valued at USD 1,700,000 (AUD 2,550,000) and is expected to be fulfilled by mid-2026 with manufacturing to be undertaken in Titomic’s Huntsville facility.

- Advertisement -

Under the EMD contract, Titomic will work closely with the defense partner to develop manufacturing pathways that address long-standing production delays and capacity constraints across the defense industrial base. The effort leverages Titomic’s proprietary cold-spray additive manufacturing systems, known for their ability to rapidly build high-strength, near-net-shape metal parts with minimal waste. By compressing development timelines and enabling scalable production, Titomic’s technology is positioned to help defense programs transition quickly from concept to readiness then to serial production.

- Advertisement -

This new engagement reinforces Titomic’s growing role as a strategic supplier supporting defense modernization initiatives. Around the world, defense organizations and armed forces are seeking new approaches to overcome slow manufacturing cycles, fragile supply chains, and increasing demand for complex metal components. Titomic’s capabilities offer higher throughput, enhanced material performance, and the flexibility to produce parts that are difficult, time-consuming and/or costly to manufacture through traditional methods.

- Advertisement -

“Securing this Early Manufacturing Development contract marks another important milestone for Titomic as we continue to expand our impact throughout the defense sector,” said Dr. Patti Dare, President of Titomic, USA. “Our advanced manufacturing technology is designed to break through production bottlenecks and ensure critical assets and solutions reach the warfighter in a mission-relevant timeframe. We are proud to support this initiative and look forward to strengthening our partnership with this leading defense prime.”

- Advertisement -

This announcement has been authorized for release by Titomic’s Board of Directors.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2759851/Titomic_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/titomic-secures-early-manufacturing-development-contract-with-leading-defense-prime-302642730.html

- Advertisement -
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO
Kymera Therapeutics Announces Pricing of $250 Million Public Offering
Nobu Hospitality Brings Iconic Luxury Lifestyle to Historic Krakw
Mantle, the Distribution Layer for Onchain Finance, Positioned Among Leading Layer 2s in New Messari Report
BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
TAGGED:contractdefensedevelopmentearlyleadingmanufacturingnewsprimesecurestitomicwith
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
VISTA GLOBAL EXPANDS GREATER CHINA FOOTPRINT WITH 32% ANNUAL TRAFFIC GROWTH
News

VISTA GLOBAL EXPANDS GREATER CHINA FOOTPRINT WITH 32% ANNUAL TRAFFIC GROWTH

21/05/2026
METABORA GAMES Launches ‘Puzzle & Guardians’ on LINE NEXT’s Mini Dapps to expand BORA Token Utility
Vantive partners with IDBS to drive global digital transformation in vital organ therapy
Idorsias daridorexant in women during menopausal transition age with insomnia
Laughland Teeth Whitening Kit: Ingredients, Disclosures, and What Consumers Are Researching in 2026
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?